Respiratory

Latest News

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

February 13th 2025

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.

Sanofi | Image credit: Eagle - stock.adobe.com
Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com
Ambient Toxins Linked to Disabilities in Minority Schoolchildren

December 10th 2024

RSV vaccine | Image credit: Pawel - atock.adobe.com
Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

December 6th 2024

Doctor with an image of lungs | Image credit: lungs_PRASANNAPIX
Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

November 26th 2024

Continuing Medical Education
View All
April 24th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

What We’re Reading: Panel to Hear J&J EUA Application; Senate Passes Relief Package; Heavy Metals in Baby Food
February 5th 2021

What We’re Reading: Panel to Hear J&J EUA Application; Senate Passes Relief Package; Heavy Metals in Baby Food

AJMC Staff
The FDA is scheduled to hear Johnson and Johnson's request for an emergency use authorization (EUA) for their coronavirus disease 2019 (COVID-19) vaccine later this month; Senate passes economic relief package; heavy metals found in some baby food.
Krishna M. Sundar, MD, University of Utah
February 4th 2021

Dr Krishna Sundar: Cough Hypersensitivity Is a Key Target for Patients With Chronic Cough

There needs to be a better understanding of cough drivers in patients as treatments have stopped working, said Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.
Site Logo
February 3rd 2021

Determinants of ICS Therapy Adherence in Patients With Asthma

Jian Wang, MD Cui Zhai, PhD Qingting Wang, PhD Wenhua Shi, PhD Wei Feng, PhD Xin Yan, MD Qianqian Zhang, PhD Xinming Xie, PhD Shaojun Li, MD Manxiang Li, PhD, MD
This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.
COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says
January 30th 2021

COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says

Skylar Jeremias
A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection.
What We’re Reading: J&J, Novavax Release COVID-19 Vaccine Data; Undercounted Nursing Home Deaths; Experts Encourage Double Masking
January 29th 2021

What We’re Reading: J&J, Novavax Release COVID-19 Vaccine Data; Undercounted Nursing Home Deaths; Experts Encourage Double Masking

AJMC Staff
Johnson & Johnson, Novavax, release positive results from phase 3 trials on their respective coronavirus disease 2019 (COVID-19) vaccines; report indicates undercounted nursing home deaths in New York; experts push for improved mask practices.
This Week in Managed Care: January 8, 2021
January 8th 2021

This Week in Managed Care: January 8, 2021

This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.
What We're Reading: FDA Stands Fast on COVID-19 Vaccine Dosing; Haven Dissolves; Moderna Boosts Dose Supply
January 5th 2021

What We're Reading: FDA Stands Fast on COVID-19 Vaccine Dosing; Haven Dissolves; Moderna Boosts Dose Supply

AJMC Staff
The FDA warns against making any changes to the authorized dosing schedules of coronavirus disease 2019 (COVID-19) vaccines; joint health care venture, Haven, dissolves; Moderna announced it will increase production of its vaccine by 100 million doses for 2021.
A Timeline of COVID-19 Developments in 2020
January 1st 2021

A Timeline of COVID-19 Developments in 2020

AJMC Staff
Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.
Megan Althoff, MD, PhD, University of Colorado
December 30th 2020

Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.
Top 5 Most-Read Respiratory Stories of 2020
December 29th 2020

Top 5 Most-Read Respiratory Stories of 2020

Skylar Jeremias
The top 5 most-read respiratory stories of 2020 on AJMC.com largely focused on the treatment options and risks associated with idiopathic pulmonary fibrosis (IPF) as well as how mental health and asthma are related.
Nicola Hanania, MD, MS, Baylor College of Medicine
December 23rd 2020

Dr Nicola Hanania: Exacerbation Improvement Is an Important Indicator of Patient Response to Biologics

When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
December 23rd 2020

What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll

Gianna Melillo
The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.
Top 5 Most-Read COVID-19 News of 2020
December 21st 2020

Top 5 Most-Read COVID-19 News of 2020

AJMC Staff
A look at some of our most-read news coverage of the coronavirus disease 2019 (COVID-19) pandemic.
FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next
December 17th 2020

FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next

Allison Inserro
After a daylong meeting, an FDA advisory panel agreed that the second vaccine in the United States to prevent coronavirus disease 2019 (COVID-19) should be put forward for use.
COVID-19 and Health Disparities: An Opportunity to Refocus Resources?
December 14th 2020

COVID-19 and Health Disparities: An Opportunity to Refocus Resources?

Gianna Melillo
Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.
Anne Reihman, MD, University of Colorado
December 8th 2020

Dr Anne Reihman: Latest Respiratory Research Lacks a Definition for “Adequate Response” in Biologics

Updated guidelines help to address which patients are most appropriate for biologic therapy, noted Anne Reihman, MD, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.
COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery
December 7th 2020

COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery

Gianna Melillo
With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.
ecigarette
December 5th 2020

Study Finds Young People Quit or Reduced Vaping Habits During the Pandemic

Skylar Jeremias
A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.
What We’re Reading: Record COVID-19 Deaths, Hospitalizations; CDC Revises Quarantine Guidelines; Moderna to Begin Pediatric Vaccine Trial
December 3rd 2020

What We’re Reading: Record COVID-19 Deaths, Hospitalizations; CDC Revises Quarantine Guidelines; Moderna to Begin Pediatric Vaccine Trial

AJMC Staff
The United States reports record numbers of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19); the CDC updates its quarantine recommendations; Moderna will soon start testing its COVID-19 vaccine in children.
Dan Ouellette, MD, MS, FCCP, Henry Ford Hospital
November 29th 2020

Dr Dan Ouellette: The New ERS/ATS Guidelines Provide Information on Biologic Agents

Updating guidelines requires having sufficient information on the elements that are your focus, noted Dan Ouellette, MD, MS, FCCP, senior staff physician and director of the Respiratory Ward at Henry Ford Hospital.
Site Logo
November 24th 2020

Why Even the Threat of a Twindemic Isn’t Swaying the Most Vulnerable: Black Women

Diane M. Ashton, MD, MPH
The fall season was accompanied by an urgent warning from the CDC of an impending “twindemic” of coronavirus disease 2019 and influenza. Despite the warnings, Black women are not lining up for vaccinations.
Megan Althoff, MD, PhD, University of Colorado
November 23rd 2020

Dr Megan Althoff: Updated GINA Guidelines Include Reliever Treatment With an Inhaled Corticosteroid

The 2019/2020 GINA guidelines recommend formoterol to produce better long-term outcomes in patients, noted Megan Althoff, MD, PhD, second-year fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.
What We’re Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage
November 23rd 2020

What We’re Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage

AJMC Staff
AstraZeneca announced that its vaccine against coronavirus disease 2019 (COVID-19) could be up to 90% effective; FDA grants emergency use authorization (EUA) for antibody cocktail used against COVID-19; spotlighting shortage of specialists to operate ventilators.
child holding inhaler
November 20th 2020

Self-Management Education, Vaccines, Other Asthma Interventions Could Reduce Health Spending and Utilization

Skylar Jeremias
A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.
What We’re Reading: Pfizer to Submit EUA Application; WHO Recommends Against Remdesivir; CDC Warns Against Holiday Travel
November 20th 2020

What We’re Reading: Pfizer to Submit EUA Application; WHO Recommends Against Remdesivir; CDC Warns Against Holiday Travel

AJMC Staff
Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.
Infant on a nebulizer
November 20th 2020

Implementing Certain Asthma Interventions Could Reduce Health Spending, Utilization

Skylar Jeremias
A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.
Anthony L. Loschner, MD, Virginia Tech Carilion School of Medicine
November 17th 2020

Dr Anthony Loschner Expounds on the Benefits of AI in Pulmonary Medicine

Artificial intelligence (AI) frees up time for clinicians, noted Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine.
What We’re Reading: FDA Authorizes Antibody Treatment; ND Attempts to Ease Stress on Hospitals; Fruit Consumption Among Children
November 10th 2020

What We’re Reading: FDA Authorizes Antibody Treatment; ND Attempts to Ease Stress on Hospitals; Fruit Consumption Among Children

AJMC Staff
FDA approves a coronavirus disease 2019 (COVID-19) antibody treatment; North Dakota braces hospitals for surging cases; fruit consumption among children is low.
COVID-19
November 9th 2020

Pfizer Says Vaccine 90% Effective; Biden Team Announces COVID-19 Transition Panel

Allison Inserro
Pfizer said interim data on its coronavirus disease 2019 (COVID-19) vaccine show 90% efficacy; meanwhile, President-elect Joe Biden released the names of his coronavirus advisory board.
pregnant woman in hospital
November 9th 2020

Safe Pregnancy Is Possible for Women With ILD, Study Finds

Skylar Jeremias
In contrast with previous research, a new study suggests that women with interstitial lung disease (ILD) may not need to avoid or terminate pregnancy.
<1
...
67891011121314
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo